FDA Inspection 904602 — Adare Pharmaceuticals, Inc.

Adare Pharmaceuticals, Inc. — FEI 1525864

The FDA completed an inspection of Adare Pharmaceuticals, Inc. on November 14, 2014 in Vandalia, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 14, 2014
Fiscal Year
2015
Product Type
Devices
Project Area
Compliance: Devices
Location
Vandalia, OH (United States)